Literature DB >> 9179365

Stimulation of the specific immune system by mistletoe extracts.

S Fischer1, A Scheffler, D Kabelitz.   

Abstract

We have investigated the in vitro responsiveness of T cells from mistletoe-treated cancer patients and untreated donors to various preparations of mistletoe extracts. Proliferation of peripheral blood mononuclear cells from treated but not from untreated patients was observed in response to therapeutically used mistletoe extracts prepared from apple (mali) or pine (pini) host trees. The strongest proliferation was induced by vesicle preparation of mali extract. Using a newly developed flow cytometry assay (standard cell dilution assay), we determined that cell growth was restricted to CD4+ T cells. Analysis with a panel of monoclonal antibodies against variable regions of the T cell receptor beta chain (V beta) revealed an oligoclonal pattern of CD4+ T cell activation. These results indicate that therapeutic administration of mistletoe extracts sensitized a restricted set of CD4+ T lymphocytes in mistletoe-treated patients. Lymphocytes from untreated donors are only stimulated with heat-treated mistletoe extracts. The responding T cells are gamma delta T cells and express variable T cell receptor elements V gamma 9 and V delta 2. The gamma delta-stimulating activity of heat-treated mistletoe extracts is sensitive to treatment with alkaline phosphatase but not with proteinase K, indicating that the ligands are non-proteinaceous phosphate-containing compounds.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179365     DOI: 10.1097/00001813-199704001-00008

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  6 in total

Review 1.  Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system.

Authors:  C T Morita; R A Mariuzza; M B Brenner
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo.

Authors:  Lucie Heinzerling; Volker von Baehr; Christa Liebenthal; Rüdiger von Baehr; Hans-Dieter Volk
Journal:  J Clin Immunol       Date:  2006-05-17       Impact factor: 8.317

3.  Active Chinese mistletoe lectin-55 enhances colon cancer surveillance through regulating innate and adaptive immune responses.

Authors:  Yan-Hui Ma; Wei-Zhi Cheng; Fang Gong; An-Lun Ma; Qi-Wen Yu; Ji-Ying Zhang; Chao-Ying Hu; Xue-Hua Chen; Dong-Qing Zhang
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

4.  Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients.

Authors:  Megan L Steele; Jan Axtner; Antje Happe; Matthias Kröz; Harald Matthes; Friedemann Schad
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-19       Impact factor: 2.629

5.  Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma In Vitro and In Vivo in Glioblastoma Bearing Mice.

Authors:  Sonja Schötterl; Jennifer T Miemietz; Elena I Ilina; Naita M Wirsik; Ingrid Ehrlich; Andrea Gall; Stephan M Huber; Hans Lentzen; Michel Mittelbronn; Ulrike Naumann
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-03       Impact factor: 2.629

6.  Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).

Authors:  Jenny Eggenschwiler; Leopold von Balthazar; Bianca Stritt; Doreen Pruntsch; Mac Ramos; Konrad Urech; Lukas Rist; A Paula Simões-Wüst; Angelika Viviani
Journal:  BMC Complement Altern Med       Date:  2007-05-10       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.